Aytu Bioscience vs Cell Source, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Aytu Bioscience and Cell Source, Inc. are worth about the same: $21 M and $20 M (market caps of Oct 26, 2026 for Aytu Bioscience and Dec 25, 2022 for Cell Source, Inc.). Cell Source, Inc.'s value is the last on file, from Dec 25, 2022: no market-data feed is connected for its exchange yet.
- Both made a net loss: $14 M for Aytu Bioscience and $5 M for Cell Source, Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Aytu Bioscience AYTU · #24,234 in the world | Cell Source, Inc. CLCS |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | — |
| Size | ||
| Market cap | $21 M | $20 M* |
| Revenue | $58 M | — |
| Net income | $-14 M | $-5 M▲ best |
| Valuation | ||
| Price to sales | 0.4× | — |
| Price to book | 0.6× | — |
| Free cash flow yield | 15.7% | — |
| Profitability | ||
| Gross margin | 64.0% | — |
| Operating margin | -14.4% | — |
| Net margin | -24.8% | — |
| Return on equity | -52.5% | — |
| Growth | ||
| Revenue growth | -13.3% | — |
| Revenue growth, 3 years a year | -18.8% | — |
| Financial strength | ||
| Debt to equity | 0.3× | — |
| Interest cover | -4.4× | — |
| Cash | ||
| Free cash flow margin | 5.7% | — |
| Strength scores | ||
| Piotroski F-score | 4 of 9 | — |
| Altman Z-score zone | distress | — |
| Data as of | Market cap Oct 2026; ratios FY2026 | Market cap Dec 2022; ratios FY2024 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Aytu Bioscience or Cell Source, Inc.?
Aytu Bioscience and Cell Source, Inc. are worth about the same: $21 M and $20 M (market caps of Oct 26, 2026 for Aytu Bioscience and Dec 25, 2022 for Cell Source, Inc.). Cell Source, Inc.'s value is the last on file, from Dec 25, 2022: no market-data feed is connected for its exchange yet.
Which makes more money, Aytu Bioscience or Cell Source, Inc.?
Both made a net loss: $14 M for Aytu Bioscience and $5 M for Cell Source, Inc.
More about Aytu Bioscience
More about Cell Source, Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.